Skip to main content
. 2020 Dec 7;8:218. doi: 10.1186/s40478-020-01097-z

Table 2.

Associations between MAPT haplotypes and risk of CBD

Haplotype MAPT variant Haplotype frequency (%) Association with CBD
rs1467967 rs242557 rs3785883 rs2471738 rs8070723 rs7521 CBD patients (N = 230) Controls (N = 1312) OR (95% CI) P value
H1b G G G C A A 20.2 16.0 1.31 (1.00, 1.72) 0.049
H1c A A G T A G 15.2 11.3 1.49 (1.11, 2.00) 0.009
H1d A A G C A A 10.9 7.1 1.76 (1.22, 2.52) 0.002
H1e A G G C A A 7.5 9.0 0.92 (0.62, 1.36) 0.66
H1f G G A C A A 0.0 1.2 N/A1 0.14
H1g G A A C A A 1.6 1.1 1.45 (0.53, 3.96) 0.47
H1h A G A C A A 5.4 4.1 1.22 (0.72, 2.08) 0.47
H1i G A G C A A 5.9 4.4 1.65 (1.01, 2.70) 0.047
H1l A G A C A G 3.7 3.0 1.10 (0.61, 1.99) 0.75
H1m G A G C A G 1.6 2.9 0.77 (0.36, 1.64) 0.50
H1o A A A C A A 3.5 2.3 1.81 (0.93, 3.50) 0.080
H1p G G G T A G 0.9 1.5 0.82 (0.28, 2.43) 0.72
H1q A A G T A A 1.3 1.0 1.49 (0.57, 3.89) 0.42
H1r A G G T A G 2.6 1.1 2.03 (0.83, 4.93) 0.12
H1u A A G C A G 4.4 2.4 1.60 (0.87, 2.95) 0.13
H1v G G A T A G 1.7 1.2 1.10 (0.40, 3.03) 0.85
H1x G A A T A G 2.2 1.3 1.54 (0.64, 3.68) 0.34
H1y A A A T A G 0.5 1.6 0.54 (0.15, 1.95) 0.35
H2 A G G C G G 7.1 22.7 0.26 (0.18, 0.38) 2 × 10−12

ORs, 95% CIs, and P values result from score tests of association that were adjusted for age and sex. ORs correspond to each additional copy of the given haplotype. P values < 0.0026 are considered as statistically significant after applying a Bonferroni correction for multiple testing

CBD corticobasal degeneration, OR odds ratio, CI confidence interval

1The H1f haplotype was not observed in CBD cases, and therefore estimation of an OR was not possible